Get the Stockscreener App
0.402
0.50%
0.002
After Hours:
.41
0.008
+1.99%
Scienture Holdings Inc stock is traded at $0.402, with a volume of 294.49K.
It is up +0.50% in the last 24 hours and down -2.95% over the past month.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
See More
Previous Close:
$0.40
Open:
$0.41
24h Volume:
294.49K
Relative Volume:
0.11
Market Cap:
$16.33M
Revenue:
$653.40K
Net Income/Loss:
$-20.19M
P/E Ratio:
-0.2222
EPS:
-1.8091
Net Cash Flow:
$-11.11M
1W Performance:
-0.25%
1M Performance:
-2.95%
6M Performance:
-23.88%
1Y Performance:
-54.83%
1-Day Range:
$0.39
$0.419
1-Week Range:
$0.3795
$0.419
52-Week Range:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings Inc
Sector
Industry
Phone
(800) 261 0281
Address
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.402 | 16.25M | 653.40K | -20.19M | -11.11M | -1.8091 |
HITI
High Tide Inc
|
2.39 | 214.47M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.12 | 46.44M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.1228 | 17.83M | 0 | 0 | 0 | 0.00 |
WGRX
Wellgistics Health Inc
|
0.0827 | 13.45M | 23.34M | -101.27M | -11.74M | -1.2919 |
Scienture Holdings Inc Stock (SCNX) Latest News
Scienture Holdings Reports 449% Revenue Growth and 95.6% Gross Margin Expansion in Q1 2026, Driven by Arbli and REZENOPY Launches - Minichart
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-than-expected loss drives positive surprise - Newser
Scienture Holdings (SCNX) Faces Selling Pressure Near Key Support LevelViral Trade Signals - Newser
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Significant EPS Beat Highlights Cost Discipline and Operational ProgressViral Trade Signals - Newser
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
Scienture Holdings (SCNX) Q1 2026 Earnings Surprise: EPS $-0.08, Up SignificantViral Trade Signals - Newser
Scienture Holdings Releases Q1 2026 Financial Results - AlphaStreet
Scienture Holdings, Inc. released its financial results and business progress for the first quarter of 2026. - Bitget
Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady - TradingView
SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion - The Manila Times
SCIENTURE、2026年第1四半期の業績を発表 大幅な収益増と粗利益率拡大が目立つ - Moomoo
Scienture Holdings Secures $11.4 Million Structured Financing Deal - TipRanks
Scienture Holdings (SCNX) Q4 2025 Earnings: EPS $-0.11 Beats EstimatesTrading Community Hub - Newser
Scienture Holdings Inc (FRA:4E4) Stock Price, Trades & News - GuruFocus
Scienture Holdings: Q1 Earnings Snapshot - marketscreener.com
Scienture Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Scienture Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Number of shareholders of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
TradingKey - TradingKey
Scienture (SCNX) Secures Patent for Innovative Losartan Suspensi - GuruFocus
Scienture secures $11M debt financing for product launches By Investing.com - Investing.com South Africa
Scienture secures $11M debt financing for product launches - Investing.com UK
Scienture secures $11.0 million in non-dilutive debt financing to accelerate growth of approved product portfolio and advancement of research and development pipeline - marketscreener.com
Scienture secures $11 million in non-dilutive debt financing - Investing.com
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline - The Manila Times
$11M debt funds Scienture's hypertension drug and overdose spray - Stock Titan
Scienture Holdings Secures $11M Debt Financing Via Note Purchase Agreement >SCNX - Moomoo
Scienture Holdings, Inc. Secures $11 Million in Non-Dilutive Debt Financing - marketscreener.com
Scienture Holdings Issues Updated Investor Presentation Disclosure - The Globe and Mail
Scienture receives third patent for liquid losartan product - Investing.com
Scienture receives third patent for liquid losartan product By Investing.com - Investing.com Australia
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 - The Manila Times
Scienture secures third patent for ARBLI™ oral suspension, extending market exclusivity to 2041. - Pluang
[8-K] Scienture Holdings, Inc. Reports Material Event - Stock Titan
Scienture Holdings, Inc. Enters $11.42 Million Secured Note Agreement with Streeterville Capital, LLC – April 2026 - Minichart
Scienture Holdings, Inc. 2025 Annual Report: Company Overview, Executive Leadership, and Financial Highlights - Minichart
Scienture Holdings Secures $11.42 Million in Secured Notes Financing From Streeterville Capital - TradingView
Scienture (NASDAQ: SCNX) adds 9% and 5% secured notes with asset pledges - Stock Titan
Deep 2025 loss at Scienture (NASDAQ: SCNX) after $26,346,050 impairments - Stock Titan
MSN Money - MSN
SCNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Scienture granted 180-day extension by Nasdaq to regain compliance - MSN
Scienture Holdings Inc Stock (SCNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):